EUVIMEDEUVIMED entdecken
Open Access

Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation

Sin Ho Kweon, Hye Guk Ryu, Seung-Hwan Kwon, Hyeonwoo Park, Saebom Lee, Nam-Shik Kim, Shi-Xun Ma, Hee-Jung Jee, Sangjune Kim, Han Seok Ko

Brain · 2024

DOI: 10.1093/brain/awae222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Sin Ho Kweon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Glucosylceramidase, tau Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the GBA1 gene are common genetic risk factors for Parkinson’s disease, disrupting enzymatic activity and causing lysosomal dysfunction, leading to elevated α-synuclein levels. Although the role of GBA1 in synucleinopathy is well established, recent research underscores neuroinflammation as a significant pathogenic mechanism in GBA1 deficiency. This study investigates neuroinflammation in Gba1 E326K knock-in mice, a model associated with increased risk of Parkinson’s disease and dementia. At 9 and 24 months, we assessed GBA1 protein and activity, α-synuclein pathology, neurodegeneration, motor deficits and gliosis in the ventral midbrain and hippocampus using immunohistochemistry, western blot and glucocerebrosidase assays. Additionally, primary microglia from wild-type and Gba1E326K/E326K mice were treated with α-synuclein preformed fibrils to study microglia activation, pro-inflammatory cytokines, reactive astrocyte formation and neuronal death through quantitative PCR, western blot and immunocytochemistry analyses. We also evaluated the effects of gut inoculation of α-synuclein preformed fibrils in Gba1 E326K mice at 7 months and striatal inoculation at 10 months after injection, assessing motor/non-motor symptoms, α-synuclein pathology, neuroinflammation, gliosis and neurodegeneration via behavioural tests, immunohistochemistry and western blot assays. At 24 months, Gba1 E326K knock-in mice showed reduced glucocerebrosidase enzymatic activity and glucosylceramide build-up in the ventral midbrain and hippocampus. Increased pro-inflammatory cytokines and reactive astrocytes were observed in microglia and astrocytes from Gba1 E326K mice treated with pathological α-synuclein preformed fibrils. Gut inoculation of α-synuclein preformed fibrils increased Lewy body accumulation in the hippocampal dentate gyrus, with heightened microglia and astrocyte activation and worsened non-motor symptoms. Intrastriatal injection of α-synuclein preformed fibrils induced motor deficits, reactive glial protein accumulation and tauopathy in the prefrontal cortex and hippocampus of Gba1 E326K mice. GBA1 deficiency attributable to the Gba1 E326K mutation exacerbates neuroinflammation and promotes pathogenic α-synuclein transmission, intensifying disease pathology in Parkinson’s disease models. This study enhances our understanding of how the Gba1 E326K mutation contributes to neuroinflammation and the spread of pathogenic α-synuclein in the brain, suggesting new therapeutic strategies for Parkinson’s disease and related synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinGlucosylceramidasetau ProteinsAnimalsMiceNeurogliaMice, TransgenicMicrogliaGene Knock-In TechniquesGliosisParkinson DiseaseMaleNeuroinflammatory DiseasesBrainDisease Models, Animal

Stichwörter der Autor:innen

GBA1E326K mutationParkinson’s diseasemicrogliaα-synuclein

Substanzen

alpha-SynucleinGlucosylceramidasetau Proteins

Autor:innen und Institutionen

  • Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Chungbuk 28644, Republic of Korea.
  • Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
  • Department of Information and Statistics, Chungbuk National University, Cheongju, Chungbuk 28644, Republic of Korea.

Förderung

  • NINDS NIH HHS
  • NIH
  • National Research Foundation of Korea
  • The Michael J. Fox Foundation for Parkinson's Research
  • Aligning Science Across Parkinson's
  • NINDS
  • The Michael J. Fox Foundation for Parkinson’s Research
  • Aligning Science Across Parkinson’s

Zitieren

APA

Kweon, S. H., Ryu, H. G., Kwon, S. H., Park, H., Lee, S., Kim, N. S., Ma, S. X., Jee, H. J., Kim, S., & Ko, H. S. (2024). Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation. Brain. https://doi.org/10.1093/brain/awae222

Vancouver

Kweon SH, Ryu HG, Kwon SH, Park H, Lee S, Kim NS, et al. Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation. Brain. 2024. doi:10.1093/brain/awae222

BibTeX
@article{Kweon2024,
  author = {Kweon, Sin Ho and Ryu, Hye Guk and Kwon, Seung-Hwan and Park, Hyeonwoo and Lee, Saebom and Kim, Nam-Shik and Ma, Shi-Xun and Jee, Hee-Jung and Kim, Sangjune and Ko, Han Seok},
  title = {Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae222}
}
Kostenlos starten →